March 8, 2018 / 9:31 PM / 7 months ago

BRIEF-AcelRx Pharma Q4 Loss Per Share $0.20

March 8 (Reuters) - AcelRx Pharmaceuticals Inc:

* ACELRX PHARMACEUTICALS REPORTS FOURTH QUARTER 2017 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.20

* Q4 EARNINGS PER SHARE VIEW $-0.20 -- THOMSON REUTERS I/B/E/S

* ANTICIPATED PDUFA DATE FOR DSUVIA IN Q4 2018

* EXPECTED FDA ADVISORY COMMITTEE MEETING FOR DSUVIA IN Q3 2018

* ANTICIPATES RESUBMISSION OF NDA FOR ZALVISO IN H2 2018

* QTRLY TOTAL REVENUE 740,000 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below